These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27679424)

  • 1. Fatal hemolytic disease of the newborn caused by an antibody to KEAL, a new low-prevalence Kell blood group antigen.
    Scharberg EA; Wieckhusen C; Luz B; Rothenberger S; Stürzel A; Rink G; Richter E; Delle Chiaie L; Burgos A; Lomas-Francis C; Bugert P
    Transfusion; 2017 Jan; 57(1):217-218. PubMed ID: 27679424
    [No Abstract]   [Full Text] [Related]  

  • 2. Possible suppression of fetal erythropoiesis by the Kell blood group antibody anti-Kp(a).
    Tuson M; Hue-Roye K; Koval K; Imlay S; Desai R; Garg G; Kazem E; Stockman D; Hamilton J; Reid ME
    Immunohematology; 2011; 27(2):58-60. PubMed ID: 22356520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fetal erythroblastosis in Kell incompatibility].
    Fuith LC; Bichler A; Schönitzer D
    Geburtshilfe Frauenheilkd; 1987 Feb; 47(2):131-3. PubMed ID: 3471624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia.
    Vaughan JI; Manning M; Warwick RM; Letsky EA; Murray NA; Roberts IA
    N Engl J Med; 1998 Mar; 338(12):798-803. PubMed ID: 9504940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rapid and severe development of fetal hemolytic disease due to anti-Kell antibodies].
    Frère MC; Schaaps JP; Thoumsin H; Retz MC; Rif J; Rigo J; De Cortis T; Lambotte R; Senterre J; Sondag-Thull D
    Rev Med Liege; 1995 Feb; 50(2):63-6. PubMed ID: 7899747
    [No Abstract]   [Full Text] [Related]  

  • 6. Kell alloimmunization, hemolytic disease of the newborn, and perinatal management.
    Wenk RE; Goldstein P; Felix JK
    Obstet Gynecol; 1985 Oct; 66(4):473-6. PubMed ID: 3931011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Kell in pregnancy.
    Vaughan JI; Warwick R; Welch CR; Letsky EA
    Br J Obstet Gynaecol; 1991 Sep; 98(9):944-5. PubMed ID: 1911618
    [No Abstract]   [Full Text] [Related]  

  • 8. First case of hemolytic disease of the newborn due to anti-Ula antibodies.
    Sakuma K; Suzuki H; Ohto H; Tsuneyama H; Uchikawa M
    Vox Sang; 1994; 66(4):293-4. PubMed ID: 8079454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemolytic disease of the newborn due to Kell sensitization].
    Beller U; Hochner-Celnikier D; Ron M; Palti Z; Beyth Y
    Harefuah; 1981 Jul; 101(1-2):14-5. PubMed ID: 7319365
    [No Abstract]   [Full Text] [Related]  

  • 10. Pancytopenia due to suppressed hematopoiesis in a case of fatal hemolytic disease of the newborn associated with anti-K supported by molecular K1 typing.
    Wagner T; Resch B; Reiterer F; Gassner C; Lanzer G
    J Pediatr Hematol Oncol; 2004 Jan; 26(1):13-5. PubMed ID: 14707704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An innovative test for non-invasive Kell genotyping on circulating fetal DNA by means of the allelic discrimination of K1 and K2 antigens.
    Cro' F; Lapucci C; Vicari E; Salsi G; Rizzo N; Farina A
    Am J Reprod Immunol; 2016 Dec; 76(6):499-503. PubMed ID: 27730708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemolytic disease of the newborn due to anti-k.
    Duguid JK; Bromilow IM
    Vox Sang; 1990; 58(1):69. PubMed ID: 2316215
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemolytic disease of the newborn: progenitor cells and late effects.
    Luban NL
    N Engl J Med; 1998 Mar; 338(12):830-1. PubMed ID: 9504946
    [No Abstract]   [Full Text] [Related]  

  • 14. Haemolytic disease of the newborn due to anti-K antibodies.
    de Jonge N; Martens JE; Milani AL; Krijnen JL; van Krimpen C; Ponjee GA
    Eur J Obstet Gynecol Reprod Biol; 1996 Jul; 67(1):69-72. PubMed ID: 8789754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kell sensitization in pregnancy.
    Caine ME; Mueller-Heubach E
    Am J Obstet Gynecol; 1986 Jan; 154(1):85-90. PubMed ID: 3946507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemolytic disease of the newborn caused by maternal allo-immunization against erythrocyte antigens other than A, B and rhesus D].
    Monestier M; Rigal D; Juron-Dupraz F; Meyer F
    J Gynecol Obstet Biol Reprod (Paris); 1984; 13(6):671-80. PubMed ID: 6520354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three novel alleles in the Kell blood group system resulting in the Knull phenotype and the first in a Native American.
    Moulds JM; Persa R; Rierson D; Billingsley KL; Noumsi GT; Hue-Roye K; Reid ME
    Transfusion; 2013 Nov; 53(11 Suppl 2):2867-71. PubMed ID: 23581548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Kell blood group system].
    Endoh T; Watanabe N
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():760-3. PubMed ID: 20942182
    [No Abstract]   [Full Text] [Related]  

  • 19. The second example of anti-K22 and a family genetically informative for K and K22.
    Manny N; Levene C; Harel N; Schneiderman S; Simon A; Daniels GL
    Vox Sang; 1985; 49(2):135-7. PubMed ID: 4036083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Kell antibodies in pregnancy].
    Rempen A; Schweppe KW
    Z Geburtshilfe Perinatol; 1983; 187(4):183-90. PubMed ID: 6684844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.